9 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ROVO Mechanical Thrombectomy Device

FDA 510(k)
FDA Class 2 ·Cardiovascular

VALULINE

FDA UDI
BENCO DENTAL SUPPLY CO.·00366975010292·

TRANSTAR INTRACRANIAL PRESSURE TRANSDUCER, MODEL MX950ICP

FDA 510(k)
FDA Class 2 ·Neurology

EDWARD PROPLEGE PERIPHERAL RETROGRADE CARDIOPLEGIA DEVICE

FDA 510(k)
FDA Class 2 ·Cardiovascular

LIGASURE ATLAS HANDSWITCHING 20CM

FDA Adverse Event
Malfunction ·COVIDIEN LP (US SURGICAL)·Product code GEI·October 31, 2008

COMPREHENSIVE REVERSE SHOULDER GLENOSPHERE BASEPLATE

FDA Adverse Event
Injury ·BIOMET ORTHOPEDICS·Product code KWS·August 23, 2011

M2A-MAGNUM PF CUP 58ODX52ID

FDA Adverse Event
Injury ·BIOMET ORTHOPEDICS·Product code KWA·July 11, 2013

BIOMET StageOne Knee Tibial Cement Spacer Mold, 75 MM, Silicone, Sterile, Item 433175.

FDA Enforcement
Class II ·Terminated·Biomet, Inc.·April 15, 2020

Brand Name: SenTiva" Product Name: VNS Therapy" SenTiva", Model 1000 Model/Catalog Number: 1000 Software Version: NA Product Description: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS Therapy generator, lead, and external programming system used to change stimulation settings. The generator is an implantable, multi-programmable pulse generator that delivers electrical signals to the vagus nerve through the lead. The generator is housed in a hermetically sealed titanium case and is powered by a single battery. Electrical signals are transmitted from the generator to the vagus nerve by the lead. The lead and the generator make up the implantable portion of the VNS Therapy System. The VNS Therapy Programming System includes a computer pre-installed with VNS Therapy programming software and a programming wand. The physician uses the programming system to read and change generator settings. The Model 1000 Generator was commercially approved for distribution in the U.S. on October 3, 2017 via PMA P970003/S210. Component: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS).

FDA Enforcement
Class II ·Ongoing·LivaNova USA, Inc.·February 5, 2025